APLB CBER stands for Animal Plant Health Inspection Service (APHIS) Animal Disease Preparedness and Response Program (ADPRP) Center for Biologics Evaluation and Research (CBER). It is a term used to refer to a specific program within the APHB APHIS organization in the United States.
The APHB APHIS is an agency of the United States Department of Agriculture (USDA), responsible for protecting and promoting the health of animals, plants, and the environment. Within the APHB APHIS, the Animal Disease Preparedness and Response Program (ADPRP) focuses on the prevention, control, and eradication of animal diseases and biological threats.
The Center for Biologics Evaluation and Research (CBER) is a specific unit within the ADPRP that is responsible for evaluating and regulating biological products. This includes vaccines, blood products, and other biologics used for the prevention, treatment, or diagnosis of animal diseases. CBER ensures the safety, purity, potency, and effectiveness of these biologics. It also provides scientific expertise, guidance, and support to stakeholders involved in disease prevention and response efforts.
Overall, APLB CBER refers to the specific program within the APHB APHIS organization that is dedicated to the evaluation, regulation, and management of biological products for animal disease preparedness and response.
